Biogen Inc. buy matumba
Start price
07.12.11
/
50%
€83.50
Target price
10.05.12
€102.75
Performance (%)
23.28%
End price
10.05.12
€102.94
Summary
This prediction ended on 10.05.12 with a price of €102.94. The prediction had a final performance of 23.28%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -2.733% | -2.733% | 25.094% | -38.930% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % | 58,55 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % | 80,51 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % | 62,78 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % | 54,39 % |
Comments by matumba for this prediction
In the thread Biogen Inc. diskutieren
38% Gewinnsteigerung
38% Gewinnsteigerung im 3. Quartal, der älteste Biotechunternehmer läßt die Mitbewerber alt aussehen.